A human cardiomyocyte-based cellular model mimicking cardiac ischemia.

Area of Science:

• Cardiovascular Research
• Stem Cell Biology
• Cellular Toxicology

Background:

• Ischemic heart disease is a leading global health concern, often studied in animal models.
• Developing human cellular models is crucial for accelerating the discovery of novel therapeutic molecules.
• Existing research faces limitations due to the scarcity of effective in vitro models for cardiomyocyte ischemic stress.

Purpose of the Study:

• To develop a novel in vitro model of ischemic stress using human cardiomyocytes derived from induced pluripotent stem cells.
• To investigate the effects of simulated cardiac ischemia and inflammation on cardiomyocyte function and viability.
• To establish a platform for screening potential therapeutic agents for ischemic heart disease.

Main Methods:

• Induced pluripotent stem cells were differentiated into human cardiomyocytes.
• Cardiomyocytes were cultured as monolayers or spheroids and exposed to oxygen and glucose deprivation to induce ischemia.
• Cells were subsequently treated with tumor necrosis factor alpha (TNF-α) and interleukin 6 (IL-6) to mimic inflammation, followed by analysis of cellular toxicity, DNA damage, mitochondrial function, and morphology.

Main Results:

• The novel in vitro model successfully induced progressive cellular toxicity, including increased apoptosis and DNA breaks.
• Observed effects included mitochondrial and metabolic dysfunction, loss of contractile function, and significant morphological alterations.
• The model recapitulated key features of ischemic injury and post-ischemic inflammation in cardiomyocytes.

Conclusions:

• The developed in vitro model provides a valuable platform for understanding the mechanisms of cardiomyocyte ischemic stress.
• This model holds promise for screening novel therapeutic molecules to protect cardiomyocytes from ischemic injury.
• The approach aligns with ethical principles by reducing reliance on animal models for research.